We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for real-time alerts, custom portfolio, and market movers
The current VRTX market cap is 101.64B. The company's latest EPS is USD 13.8223 and P/E is 28.47.
| Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Revenue | 2.34B | 2.3B | 2.37B | 2.5B | 2.48B |
| Operating Income | 1.13B | 1.03B | 777.1M | 1.03B | 1.04B |
| Net Income | 930.5M | 818.9M | 699.8M | 915.7M | 1.04B |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Revenue | 4.16B | 6.21B | 7.58B | 8.99B | 9.92B |
| Operating Income | 1.2B | 2.86B | 2.78B | 4.31B | 3.83B |
| Net Income | 1.18B | 2.71B | 2.34B | 3.32B | 3.57B |
| Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Assets | 16.71B | 18.15B | 18.97B | 20.35B | 21.73B |
| Total Liabilities | 3.68B | 4.24B | 4.54B | 4.88B | 5.21B |
| Total Equity | 13.03B | 13.91B | 14.43B | 15.47B | 16.51B |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Assets | 8.32B | 11.75B | 13.43B | 18.15B | 22.73B |
| Total Liabilities | 2.23B | 3.06B | 3.33B | 4.24B | 5.15B |
| Total Equity | 6.09B | 8.69B | 10.1B | 13.91B | 17.58B |
| Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Operating | 3.05B | 4.13B | 899.9M | 2.03B | 3.3B |
| Investing | -496.7M | -321.1M | -1.83B | -2.14B | -2.26B |
| Financing | -107.9M | -67.7M | -294.7M | -277.4M | -442.4M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Operating | 1.57B | 3.25B | 2.64B | 4.13B | 3.54B |
| Investing | -1.24B | 99.39M | -340.9M | -321.1M | -3.14B |
| Financing | 126.77M | -505.28M | -1.48B | -67.7M | -562.2M |
| Market Cap | 101.64B |
| Price to Earnings Ratio | 28.47 |
| Price to Sales Ratio | 10.25 |
| Price to Cash Ratio | 9.8 |
| Price to Book Ratio | 5.78 |
| Dividend Yield | - |
| Shares Outstanding | 258.31M |
| Average Volume (1 week) | 1.01M |
| Average Volume (1 Month) | 903.76k |
| 52 Week Change | 20.51% |
| 52 Week High | 448.40 |
| 52 Week Low | 316.43 |
| Spread (Intraday) | 1.28 (0.32%) |
| Company Name | Vertex Pharmaceuticals Inc |
| Address |
50 northern avenue boston, massachusetts 02210 |
| Website | https://www.vrtx.com |
| Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
